drugset / Trial / NCT01367756
A Study of RO4995819 in Combination With Citalopram in Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
This randomized, double-blind, parallel-arm study will assess the safety and tolerability of RO4995819 in combination with citalopram in healthy volunteers. Subjects will receive citalopram orally on Days 1-9 and be randomized to receive either RO4995819 orally or placebo in combination with citalopram on Days 10-16. Safety follow-up will be up to Day 58.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO4995819 | Small molecule | — | Oral |
| Background | Citalopram | Small molecule | — | Oral |
Indications
No indication recorded.